Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 3342Erstellt: 26. Oktober 2026

2-(3-Phenoxyphenyl)propionsure

Fenoprofen D3 · Einecs 249-770-1 · 2-(3-Phenoxyphenyl) · 3-Phenoxyhydratropic acid · Fenoprofen, racemic mixture · 2-(m-Phenoxyphenyl)propionic acid · α-Methyl-3-phenoxybenzeneacetic acid · Benzeneacetic acid, a-methyl-3-phenoxy-

https://huagongshe.com/de/chemical/3342

Molekülstruktur von 2-(3-Phenoxyphenyl)propionsure

Identifikatoren & physikalische Daten

CAS No.29679-58-1
SummenformelC15H14O3
Durchschnittliche Molmasse242,27 g/mol
Monoisotopische Masse242,09429431 g/mol
SMILESCC(C(=O)O)c1cccc(Oc2ccccc2)c1
InChIKeyRDJGLLICXDHJDY-UHFFFAOYSA-N
PubChem CID3342
ChEMBLCHEMBL1297
ChEBICHEBI:5004
EC No.249-770-1
DTXSIDDTXSID9023045
Lokaler Name2-(3-Phenoxyphenyl)propionsure

Chemische & physikalische Eigenschaften

XLogP3,3
Polarare Oberfläche (TPSA)46,5
H-Brücken-Donoren1
H-Brücken-Akzeptoren3
Frei drehbare Bindungen4
Schwere Atome18
Formalladung0
Komplexität271
LogP (Verteilungskoeffizient)3.13.45
Color/FormVISCOUS OIL
LöslichkeitSlight (calcium salt)8.11e-02 g/LDMSO : 100 mg/mL (412.76 mMNeed ultrasonic)
Human DrugsBreast FeedingLactationMilk, HumanAnalgesic AgentsAnti-inflammatory Agents, NonsteroidalPharmaceuticals
Siedepunkt168-171 °C @ 0.11 MM HG168-171 °C(Press: 0.11 Torr)
Schmelzpunkt168-171
BrechungsindexINDEX OF REFRACTION: 1.5742 @ 25 °C/D
Physical DescriptionSolid
Dissociation Constants4.5PKA= 7.3
Collision Cross Section157.19 Ų [M+Na]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]
Dichte1.183±0.06 g/cm3(Predicted)
LagerbedingungenStore at -20°C
pKa (Säurekonstante)4.20±0.10(Predicted)
AggregatzustandOil to Thick Oil
FarbeColourless
EPA chemische InformationenBenzeneacetic acid, ?-methyl-3-phenoxy- (29679-58-1)

Sicherheit & Vorschriften

WechselwirkungenWHEN FENOPROFEN WAS ADDED TO REGIMEN OF...PT WITH RHEUMATOID ARTHRITIS WHO WERE RECEIVING CORTICOSTEROID OR GOLD THERAPY, THERE WAS SOME EVIDENCE THAT DOSE OF STEROID COULD BE REDUCED & COMBINATION WITH GOLD WAS MORE EFFECTIVE.FOOD DELAYS ABSORPTION...& REDUCES PEAK PLASMA CONCN (ABOUT 30%) & TOTAL ABSORPTION (ABOUT 20%), AS DOES COADMIN OF...ANTACIDS./PLASMA PROTEIN/ BINDING OF FENOPROFEN IS INHIBITED BY CONCOMITANT ADMIN OF INDOMETHACIN & PHENYLBUTAZONE... PLASMA T/2 OF FENOPROFEN IS DECR BY ASPIRIN...FENPROFEN & PROPOXYPHENE ARE ADDITIVE WHEN GIVEN TOGETHER.
HepatotoxicityProspective studies show that up to 15% of patients taking fenoprofen experience at least transient serum aminotransferase elevations. These elevations are generally transient, mild and asymptomatic, and may resolve even with drug continuation. Marked aminotransferase elevations (above 3 times the upper limit of normal (ULN) occur in less than 1% of patients.
Human Toxicity ExcerptsMOST COMMON ADVERSE REACTIONS /ORAL ADMIN/...GI EFFECTS (EG, DYSPEPSIA, CONSTIPATION, NAUSEA, VOMITING)...FEW CASES OF ULCERATION... CNS REACTIONS INCL DROWSINESS, DIZZINESS, HEADACHE, NERVOUSNESS, & CONFUSION. PRURITUS, RASH, SWEATING, PALPITATIONS, TREMOR, TINNITUS, BLURRED VISION, & DECR HEARING...SENSITIVITY TO DRUG...ELEVATIONS OF SERUM TRANSAMINASE, LACTIC DEHYDROGENASE, & ALKALINE PHOSPHATASE LEVELS...IN SOME PT. DECR IN HEMOGLOBIN & HEMATOCRIT...OCCASIONALLY. FENOPROFEN REDUCES PLATELET AGGREGATION & ADHESIVENESS & INCR BLEEDING TIME /ORAL ADMIN/..../FENOPROFEN, ORALLY/ EFFECTIVENESS IN RHEUMATOID ARTHRITIS APPEARS... COMPARABLE TO...ASPIRIN &...INCIDENCE OF GI REACTIONS & AMT OF GI BLEEDING IS LESS THAN WITH ASPIRIN....DRUGS /INCL FENOPROFEN/ HAVE BEEN ASSOC WITH FATAL GI HEMORRHAGE IN RARE CASES.For more Human Toxicity Excerpts (Complete) data for FENOPROFEN (10 total), please visit the HSDB record page.
Drug Induced Liver InjuryBenchmark Dataset for the Liver Toxicity Knowledge Base (LTKB)fenoprofenNalfon®NSAIDs8most-DILI-concern
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Zollcode2918999090

Anwendungen & Verwendung

Verwenden

Fenoprofen is a positive allosteric modulators at melanocortin receptor 3 for treatment of inflammatory diseases in human and mouse model.